MILESTONE ONE
LIVE

Serial Number

79394254

Owner

Milestone One AG

Attorney

Stacey R. Halpern

Filing Date

Jan 17, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MILESTONE ONE Trademark

Serial Number: 79394254 • Registration: 7910000

MILESTONE ONE is a trademark filed by Milestone One AG on January 17, 2024. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Milestone One AG

Baarerstrasse 113a

Entity Type: 25

Trademark Details

Filing Date

January 17, 2024

Registration Date

August 26, 2025

Published for Opposition

July 8, 2025

Goods & Services

Medical services; outpatient and inpatient care services; pharmaceutical consultation and provision of medical information relating to pharmaceutical products; biopharmaceutical consultation and provision of medical information relating to biopharmaceutical products; medical consultation and provision of medical information with respect to medical products; medical testing; medical services provided in the context of conducting clinical studies; medical care and analysis services relating to patient treatment; provision of information relating to health and medicine; providing information in the field of medicine; providing medical information in the field of clinical studies.

Scientific and technological services, namely, scientific research, analysis, testing, advisory and consulting in the field of clinical research and the recruitment of study participants; Scientific and technological services, namely, research and design in the field of clinical research and the recruitment of study participants; providing information with respect to medical and scientific research in the field of pharmaceutical products; scientific research in the nature of conducting clinical trials for others ; conducting of scientific feasibility studies; pharmaceutical research and development services for the pharmaceutical industry; medical and scientific research, namely, conducting clinical trials for others; blood serum analysis services for scientific research purposes; scientific laboratory services; scientific research services for medical purposes; scientific and medical research and development; quality control for others; design and development of computer software.

Providing training in the field of clinical research and recruitment of study participants; providing training in the field of medical professional skills; providing training in the field of proper use of surgical, medical, dental and veterinary apparatus and instruments; providing courses of instruction and training services in the field of clinical research; arranging and conducting of conferences, congresses, seminars, symposiums, lectures, training and workshops in the field of clinical research and recruitment of study participants; organization and conducting of seminars, training, lectures, workshops, symposiums, congresses and conferences in the field of clinical research and recruitment of study participants.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 26, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 9, 2026 FICS
FINAL DISPOSITION PROCESSED
Mar 9, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 26, 2025 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 10, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 24, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 24, 2025 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 26, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 26, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 8, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 8, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 2, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 2, 2025 CNSA
REFUSAL PROCESSED BY IB
May 9, 2025 RFNP
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 22, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 22, 2025 TROA
NON-FINAL ACTION WRITTEN
Apr 15, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 24, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 24, 2025 TROA
REFUSAL PROCESSED BY IB
Sep 21, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 31, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 30, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 27, 2024 RFCR
NON-FINAL ACTION WRITTEN
Aug 26, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 13, 2024 DOCK
ASSIGNED TO EXAMINER
Aug 12, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
May 7, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 7, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 25, 2024 REPR